Decision Point Financial, LLC Ark Genomic Revolution ETF (De Transaction History

Decision Point Financial, LLC

$438 Million
Q4 2025

A detailed history of Decision Point Financial, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Decision Point Financial, LLC holds 30 shares of ARKG stock, worth $806. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$806

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2025 Jan 28, 2026	BUY	$26.89 - $33.6 $806 - $1,008	30 New	30 $0

Others Institutions Holding ARKG

# of Institutions

295

Shares Held

20.3M

Call Options Held

2.49M

Put Options Held

2.8M

Jpmorgan Chase & CO New York, NY

3.94M
Shares

$106 Million
0.01% of portfolio
Morgan Stanley New York, NY

2.83M
Shares

$76.2 Million
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

2.16M
Shares

$58.1 Million
0.01% of portfolio
Citigroup Inc

1.52M
Shares

$40.8 Million
0.02% of portfolio
Ubs Group Ag

1.3M
Shares

$34.8 Million
0.01% of portfolio

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Decision Point Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decision Point Financial, LLC with notifications on news.

Account

Decision Point Financial, LLC Ark Genomic Revolution ETF (De Transaction History